Compared with FLT3 mutation-negative patients, FLT3 mutation-positive patients had a lower inflammatory response, and FLT3-mutated AML cells were previously thought to be less responsive to exogenous cytokines, that is, exhibit lower inflammatory responses [57]. This evidence concerns the gene FLT3 and acute myeloid leukemia.